THE LONG-ACTING GLP-2 ANALOG APRAGLUTIDE PROVIDES CLINICAL BENEFIT FOR PATIENTS WITH SHORT BOWEL SYNDROME WITH INTESTINAL FAILURE AND COLON IN CONTINUITY AT 52 WEEKS

Astrid Verbiest  ^{1, 2}     Mark Krogh Hvistendahl  ³     Federico Bolognani  ⁴     Carrie Li  ⁴     Nader Youssef  ⁴     Palle Bekker Jeppesen  ⁴     Francisca Joly  ⁵     Tim Vanuytsel  ^{2, 1    
1} University of Leuven, Leuven, Belgium
² University Hospitals Leuven, Leuven, Belgium
³ Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
⁴ VectivBio AG, Basel, Switzerland
⁵ Hôpital Beaujon, Clichy, France

Topic
IBD, Small Intestine & Nutrition

Session
Breakthroughs in IBD treatment and outcomes: Late-breaking abstracts

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)